◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CYTK

Cytokinetics, Incorporated (CYTK) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Cytokinetics, Incorporated (CYTK) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 673 employees. Its market capitalization is roughly $12 billion. In the fiscal year ended 2025-12-31, CYTK reported $88M in revenue and ($785M) in net income.

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States.

Interactive charts & full statements → Open the CYTK valuation workbench →

CYTK Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$88M$18M$8M$95M
Gross Profit($328M)($321M)($323M)($146M)
Operating Income (EBIT)($612M)($536M)($496M)($324M)
Net Income($785M)($590M)($526M)($389M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CYTK Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$19M$18M$2M$67M$2M
Gross Profit$17M($87M)($97M)($46M)$0M
Operating Income (EBIT)($184M)($178M)($167M)($112M)($156M)
Net Income($206M)($183M)($306M)($134M)($161M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CYTK Free Cash Flow History

CYTK Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$1.4B$1.4B$824M$1.0B
Total Liabilities$2.1B$1.5B$1.2B$1.1B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CYTK viewer.

Other Companies in Biotechnology

← CYRXAll stocksCZFS →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.